Navigation Links
uVera Diagnostics Offers New Drug Screening Product
Date:1/10/2012

NORFOLK, Va., Jan. 10, 2012 /PRNewswire/ -- uVera Diagnostics has introduced the CR3 Keyless Split Sample Cup to its inventory. The new drug screening specimen cup provides several state-of-the-art features not available together in any other product on the market.

"This is revolutionary to the drug testing industry," said Rick Nee, president of uVera Diagnostics. "The unisex cup opening is designed for ease of use for both genders. The unique patented device is keyless, further eliminating some of the challenges involved for clients in a drug testing situation."

Most urine drug screen test sample collection cups are designed with the testing process in mind. The CR3 not only ensures the testing process, but also the collection process. This specimen cup opens at an angle with a snap-secure lid. It has a non-reversible sample split device at the bottom, which preserves the rest of the sample for additional testing, if necessary.

"This is a cost-effective alternative for employers who want to conduct their own drug screenings," said Nee. "With 99 percent accuracy, it is also an affordable at-home drug test for parents to use on their children if they suspect a problem."

The device is FDA cleared and CLIA waived. It provides results within five minutes for panels of five to 14 specific drugs, including marijuana, cocaine, amphetamines, methamphetamine and opiates, while monitoring the sample's temperature to detect tampering.

The CR3 is now available for online purchase at uveradiagnostics.com.

About uVera Diagnostics: uVera Diagnostics (http://uveradiagnostics.com/) is a manufacturer and wholesale diagnostic test kit distributor. The Virginia-based company offers FDA-cleared, CLIA-waived urine drug tests and saliva drug scree
'/>"/>

SOURCE uVera Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Quest Diagnostics Completes Acquisition of S.E.D. Medical Laboratories
2. Quest Diagnostics to Release Fourth Quarter and Full Year 2011 Financial Results
3. Span Diagnostics Ltd. Hits Bulls eye at ET NOW-IndiaMART Leaders of Tomorrow Awards 2011
4. Abaxis Animal Health Announces the Addition of a Feline Heartworm Application to the Rapid Diagnostics Product Line
5. Vermillion Completes the Acquisition of Correlogic Systems Ovarian Cancer Diagnostics Business
6. Ventana Medical Systems, Inc. and Advanced Cell Diagnostics Enter Worldwide Co-Promotion Agreement for Fully Automated RNA In Situ Hybridization Assay Systems
7. Quest Diagnostics Care360™ Named Top e-Prescribing Platform by Black Book Rankings
8. Quest Diagnostics Adds Timothy M. Ring to Board of Directors
9. Quest Diagnostics Launches Simplexa™ Dengue Test in Brazil, First Commercial Molecular Test Approved for Nations Public and Private Health Testing
10. M&A Surges, Companion Diagnostics Accelerate, and Early Detection Offers New Prospects, Finds PwCs Biennial Review of the In Vitro Diagnostics Industry
11. The 2011 Vibrio Diagnostics Market: US, Europe, Japan Test Volume and Sales Forecasts by Country
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... , Jan. 14, 2014 HeartWare International, ... innovator of less invasive, miniaturized circulatory support technologies that ... announced that it expects revenues for the fourth quarter ... full-year 2013 revenues to approximately $208 million. ...
(Date:1/14/2014)... Dynamic Healthcare Services, Inc. ("DHS"), a portfolio company of ... Home Medical Equipment, Inc. ("Progressive") of Clarion, PA ... acquisition were not disclosed. Progressive is a ... range of sleep, mobility, and respiratory products to customers in ...
(Date:1/14/2014)... Jan. 14, 2014 NineSigma , Inc., the ... Innovation Leadership Summit , May 14-16, 2014 at ... Cleveland Ohio . This is ... committed to breakthrough achievements through open innovation. Participants will ...
Breaking Medicine Technology:HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4
... Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer ... financial results for the first quarter ended March 31, 2011 ... financial markets. NxStage will also host a conference ... 2011 to discuss its first quarter financial results. To listen ...
... Novartis Pharmaceuticals Corporation ("Novartis") announced today that the ... Advisory Committee (ODAC) recommended approval of Afinitor® (everolimus) ... neuroendocrine tumors (NET) of pancreatic origin. ... from the everolimus RADIANT (RAD001 In Advanced Neuroendocrine ...
Cached Medicine Technology:NxStage® to Report First Quarter Fiscal 2011 Financial Results 2Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 2Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 3Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 4Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 5Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 6Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 7Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 8Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 9Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 10
(Date:4/23/2014)... J. O,Shea, M.D., scientific director at the National Institute ... been named the 2014 recipient of the Ross Prize ... open-access journal Molecular Medicine . The award will ... Academy of Sciences in Manhattan, followed by scientific presentations ... part of the National Institutes of Health. , The ...
(Date:4/23/2014)... The American Society for Radiation Oncology (ASTRO) has ... Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based ... therapy in the treatment of endometrial cancer. The ... 2014 issue of Practical Radiation Oncology ... The full-length guideline is available as an open-access ...
(Date:4/23/2014)... Ind. - Purdue University researchers have developed a way ... cell by using tiny gold particles with tails of ... of agricultural and biological engineering, used gold nanoparticles to ... as BRCA1 messenger RNA splice variants, which can indicate ... of these mRNA splice variants in a cell can ...
(Date:4/23/2014)... compound that targets an important brain receptor has a ... including relapse behavior, a University at Buffalo animal study ... this may be a novel lead compound for treating ... UB research was published as an online preview article ... study, the compound, RO5263397, severely blunted a broad range ...
(Date:4/23/2014)... 2014Men whose testosterone falls below normal levels are more ... and have heart disease and type 2 diabetes. A ... for further testing and possible treatment is described in ... a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. ... of Men,s Health website at http://www.liebertpub.com/jmh . ...
Breaking Medicine News(10 mins):Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 3Health News:Gold nanoparticles help target, quantify breast cancer segments in a living cell 2Health News:Novel compound halts cocaine addiction and relapse behaviors 2
... A leading authority on the aging, health and retirement of ... the ability of Americans to provide for the long term ... November 12, Dr. Dychtwald will address members of the news ... importance of long term care planning. This topic is ...
... , PHILADELPHIA, Oct. 28 Health Partners announced ... the state Children,s Health Insurance Program (CHIP). CHIP, brought ... already begun enrolling members in Philadelphia County and will ... , CHIP offers quality health insurance to all uninsured ...
... Oct. 28 Carefx Corporation , ... and safety of patient care, is listed among the " ... by IDC, a leading IT market research and advisory firm. ... Oct. 26, profiles companies "with the vision and technology to have ...
... a subsidiary of Eisai Inc., announced today that it ... Biotech Inc. for development and commercialization of an antibody ... tumors. , Under the terms of the ... for the development, manufacture and sale of the antibody. ...
... Health Foundation today announced that it has awarded The ... to create education and outreach programs that empower pharmacists, ... misuse in their communities. , According to the Ohio ... Ohio high school students have reported using a prescription ...
... LONDON, October 28 Even though no-one wants to ... to look good at the,ubiquitous Christmas Party then follow the realbuzz.com guide ... diet and healthy living go out,the window, so now,s the time to ... - we wouldn,t be realbuzz.com if we didn,t offer this piece of,advice ...
Cached Medicine News:Health News:Dr. Ken Dychtwald to Discuss Looming 'Caregiver Crunch' and the Importance of Proactive Long Term Care Planning 2Health News:Health Partners to Offer Health Insurance Through the Children's Health Insurance Program 2Health News:Carefx Named an Innovative Information Access 'Company to Watch' By Leading Market Research Firm 2Health News:Carefx Named an Innovative Information Access 'Company to Watch' By Leading Market Research Firm 3Health News:Morphotek(R), Inc. Announces a Licensing Deal With Centocor Ortho Biotech Inc. for Exclusive Development and Commercialization Rights for a Therapeutic Monoclonal Antibody 2Health News:Cardinal Health Foundation, The Ohio State University College of Pharmacy Join Forces to Prevent Prescription Medication Abuse 2Health News:The Countdown to Christmas - The realbuzz.com Guide to a Healthier You! 2
... a vacuum tube for the collection, transport ... immunophenotyping by flow cytometry. The preservative contained ... the white blood cell cluster of differentiation ... Patient samples collected in Cyto-Chex BCT are ...
Streck-ONYX-Pack is specially designed for use on Coulter® ONYX Series instruments. Each pack contains diluent and lysing agent. The shelf life is one year from date of manufacture....
... reagent manufactured for the simultaneous quantitative ... cells. Streck-Lysing Agent IIIC is for ... S Plus II, III, IV, V, ... JT Series. The shelf life is ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Medicine Products: